Rheumatology / Original Article
Renal safety and urate-lowering efficacy of febuxostat in gout patients with stage 4–5 chronic kidney disease not yet on dialysis
Sang-Hyon Kim, So-Yeon Lee, Ji-Min Kim, Chang-Nam Son
Korean J Intern Med. 2020;35(4):998-1003. Published online April 8, 2019
Background/Aims: The safety and efficacy of febuxostat in patients with stage 4–5 chronic kidney disease (CKD) are still unclear owing to a lack of studies in these patients. Therefore, we aimed to evaluate the effect of febuxostat on renal function, general safety, and efficacy in gout patients wi..
|